Search

everythinglearnresearchcommunity

for

Search:↓

Retinoic acid, glucocorticoids, and IGF1 increase IGFBP-3 production in human dermal papilla cells, affecting hair growth.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Tafluprost could be a potential treatment for hair loss by promoting hair growth phase changes.

New compounds show promise as nonsteroidal treatments for hair loss.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Two finasteride preparations are bioequivalent.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

Neurosteroids may help treat disorders with too much dopamine activity.

Finasteride 1 mg may help prevent prostate issues, but more research is needed to confirm its benefits.

Vitamin D3 affects cell differentiation in specific skin areas.

Using single dermal papillae is unreliable for analyzing androgen metabolism in hair follicles.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Estetrol helps keep scalp hair in the growth phase longer and improves hair follicle health by affecting the hair root and increasing stem cells.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

Neurosteroids help control dopamine responses in the brain.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

The method is effective and suitable for testing finasteride tablets.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

USPlus® DERM may help hair growth and reduce hair loss.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

A 15-year-old girl with rare reproductive disorders received hormone therapy to develop secondary sexual traits, but infertility persisted.